Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sergiy A, Starosyla"'
Autor:
Mariia Yu. Rybak, Anatoliy O. Balanda, Anna P. Yatsyshyna, Igor. M. Kotey, Sergiy A. Starosyla, Volodymyr G. Bdzhola, Lubov L. Lukash, Sergiy M. Yarmoluk, Michael A. Tukalo, Galyna P. Volynets
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Antibiotic resistance is a major problem of tuberculosis treatment. This provides the stimulus for the search of novel molecular targets and approaches to reduce or forestall resistance emergence in Mycobacterium tuberculosis. Earlier, we di
Externí odkaz:
https://doaj.org/article/2895faeaf24341efba42a3825c6db018
Autor:
Galyna P. Volynets, Fabian Barthels, Stefan J. Hammerschmidt, Olena V. Moshynets, Sergiy S. Lukashov, Sergiy A. Starosyla, Hanna V. Vyshniakova, Olga S. Iungin, Volodymyr G. Bdzhola, Andrii O. Prykhod’ko, Anatolii R. Syniugin, Vladislav M. Sapelkin, Sergiy M. Yarmoluk, Tanja Schirmeister
Publikováno v:
The Journal of Antibiotics. 75:321-332
Staphylococcus aureus is one of the most dangerous pathogens commonly associated with high levels of morbidity and mortality. Sortase A is considered as a promising molecular target for the development of antistaphylococcal agents. Using hybrid virtu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9070f741f09bac54f92b8fed82646a1
https://doi.org/10.1038/s41429-022-00524-8
https://doi.org/10.1038/s41429-022-00524-8
Autor:
M. V. Protopopov, O. V. Borovykov, Sergiy M. Yarmoluk, V. S. Vdovin, Olga V. Ostrynska, I. P. Borysenko, S. S. Lukashov, Yaroslav V. Bilokin, Sergiy A. Starosyla, Olexander P. Kukharenko, Volodymyr G. Bdzhola
Publikováno v:
Biopolymers and Cell. 37:62-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e554972b804abb2ddcd1dc6c4142b9a2
https://doi.org/10.7124/bc.000a4c
https://doi.org/10.7124/bc.000a4c
Autor:
Sergiy A. Starosyla, Galyna P. Volynets, Mykola V. Protopopov, Volodymyr G. Bdzhola, Denis O. Pashevin, Valentyna O. Polishchuk, Taisiia O. Kozak, Dmytro O. Stroi, Victor E. Dosenko, Sergiy M. Yarmoluk
Publikováno v:
Structural chemistry.
Protein kinase Cβ (PKCβ) is considered as an attractive molecular target for the treatment of COVID-19-related acute respiratory distress syndrome (ARDS). Several classes of inhibitors have been already identified. In this article, we developed and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc608beaf36bb336c52ae91f26ddaeb1
https://pubmed.ncbi.nlm.nih.gov/36248344
https://pubmed.ncbi.nlm.nih.gov/36248344
Autor:
M. V. Protopopov, Olga V. Ostrynska, Olexander P. Kukharenko, I. P. Borysenko, Yaroslav V. Bilokin, S. S. Lukashov, O. V. Borovykov, Sergiy M. Yarmoluk, Sergiy A. Starosyla, V. S. Vdovin, Volodymyr G. Bdzhola
Publikováno v:
Biopolymers and Cell. 36:466-476
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13f8931ede95034128d1593745e26763
https://doi.org/10.7124/bc.000a44
https://doi.org/10.7124/bc.000a44
Autor:
Sergiy M. Yarmoluk, Anatolii R. Syniugin, Galyna P. Volynets, Volodymyr G. Bdzhola, N. O. Kachaput, I. M. Koleiev, M. V. Protopopov, L. V. Pletnova, V. M. Sapelkin, V. I. Matiushok, Sergiy A. Starosyla
Publikováno v:
Biopolymers and Cell. 36:348-357
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::362f737a6ba25c8616c9fc92c62362f7
https://doi.org/10.7124/bc.000a38
https://doi.org/10.7124/bc.000a38
Autor:
Anna Iatsyshyna, L. L. Lukash, Galyna P. Volynets, Sergiy M. Yarmoluk, Yaroslav V. Bilokin, Iryna Borysenko, Andrii Gryshchenko, S. S. Lukashov, Volodymyr G. Bdzhola, T. P. Ruban, Sergiy A. Starosyla
Publikováno v:
Monatshefte für Chemie - Chemical Monthly. 150:1801-1808
Fibroblast growth factor receptor 1 (FGFR1) plays an important role in tumorigenesis, suggesting that inhibitors of this protein kinase may become important compounds for the development of anticancer agents. Using molecular docking approach, we have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::113bac8b27facdb0db0c89c6e1ea96bc
https://doi.org/10.1007/s00706-019-02493-5
https://doi.org/10.1007/s00706-019-02493-5
Autor:
Mariia Yu Rybak, S. S. Lukashov, Volodymyr G. Bdzhola, Sergiy M. Yarmoluk, O. P. Kovalenko, Sergiy A. Starosyla, Michael Tukalo, O. I. Gudzera, Helena I. Boshoff, Galyna P. Volynets
Publikováno v:
MedChemComm. 10:2161-2169
Effective treatment of tuberculosis is challenged by the rapid development of Mycobacterium tuberculosis (Mtb) multidrug resistance that presumably could be overcome with novel multi-target drugs. Aminoacyl-tRNA synthetases (AARSs) are an essential p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaf26fdbdc8cfd7123b915013f0bf357
https://doi.org/10.1039/c9md00347a
https://doi.org/10.1039/c9md00347a
Autor:
Galyna P. Volynets, L. L. Lukash, Michael Tukalo, Sergiy M. Yarmoluk, Volodymyr G. Bdzhola, Mariia Yu Rybak, Anna P Yatsyshyna, Igor M. Kotey, A. O. Balanda, Sergiy A. Starosyla
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Antibiotic resistance is a major problem of tuberculosis treatment. This provides the stimulus for the search of novel molecular targets and approaches to reduce or forestall resistance emergence in Mycobacterium tuberculosis. Earlier, we discovered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fb9fff9cabccb5d5989c75590b6f736
http://europepmc.org/articles/PMC8010095
http://europepmc.org/articles/PMC8010095
Autor:
Sergiy A. Starosyla, Galyna P. Volynets, M. V. Protopopov, Yaroslav V. Bilokin, S. S. Lukashov, V. S. Vdovin, Sergiy M. Yarmoluk, Volodymyr G. Bdzhola
Publikováno v:
Current Enzyme Inhibition. 14:152-159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f83e1fe40fcbb55e58643f884e749b50
https://doi.org/10.2174/1573408013666170929163056
https://doi.org/10.2174/1573408013666170929163056